Schedule 13D ownership disclosure
THESEUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 88369M101
Event date: 2022-06-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,335,346
- Percent of class
- 8.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-070546
- Form type
- SC 13D
- Filer
- Foresite Capital Fund V, L.P.
- CIK
- CIK 1792204
- Filed
- Jun 13, 2022
- Reporting period
- Jun 09, 2022
- Description
- Schedule 13D beneficial ownership